# Investigating Mechanistic Predictors of Interpatient Variability and Temozolomide (TMZ) Induced Haematological Toxicity for Glioma Patients

> **NCT06546631** · — · RECRUITING · sponsor: **University College Cork** · enrollment: 55 (estimated)

## Conditions studied

- Glioma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06546631
- **Lead sponsor:** University College Cork
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-22
- **Primary completion:** 2027-07
- **Final completion:** 2027-12
- **Target enrollment:** 55 (ESTIMATED)
- **Last updated:** 2026-03-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06546631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06546631, "Investigating Mechanistic Predictors of Interpatient Variability and Temozolomide (TMZ) Induced Haematological Toxicity for Glioma Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06546631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*